Navigation Links
Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients
Date:9/26/2011

lateusa.com/">wilate® is a plasma-derived, stable, highly purified concentrate of freeze-dried human von Willebrand factor (VWF) and coagulation factor VIII (FVIII). Two well-established virus inactivation steps are incorporated into the manufacturing process of wilate®, specifically a solvent/detergent (S/D) and terminal dry heat treatment.

For more information on the research, entitled "Clinical Study to Investigate the Efficacy and Safety of Human Factor VWF/VIII Concentrate (wilate®) in Subject with Inherited Type 3 Von Willebrand Disease (VWD) who Undergo Major Surgical Procedures (WONDERS)," please visit www.clinicaltrials.gov. U.S. researchers interested in participating in the study should contact Sylvia Werner, Octapharma Associate Director Clinical Operations – Coagulation, at (201) 604-1149 or sylvia.werner@octapharma.com.

About the Octapharma Group

Headquartered in Lachen, Switzerland, Octapharma AG is one of the largest human protein products manufacturers in the world and has been committed to patient care and medical innovation for over 27 years. Octapharma's core business is the development, production and sale of high quality human protein therapies from both human plasma and human cell-lines, including immune globulin intravenous (IGIV). In the U.S., Octapharma's IGIV product, octagam®  (immune globulin intravenous [human] 5%), is used to treat disorders of the immune system, and Octapharma's Albumin (human)® is indicated for the restoration and maintenance of circulating blood volume. Octapharma'
'/>"/>

SOURCE Octapharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Octapharma USA Sponsors International Advisory Board for Evaluating Treatment of Patients with von Willebrand Disease
2. Octapharma Targets Primary Immune Deficiency Research With Grant for The Mount Sinai Medical Center
3. Octapharma Clinical Trial Begins in the U.S. and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line
4. Octapharma Accepting Applications for Research Grants Focused on Human Protein Therapies
5. Octapharma USA Launches Web Resource for von Willebrand Disease Healthcare Professionals and Patients
6. FDA Confirms Orphan Drug Exclusivity Approval for wilate®, Octapharma USAs New Therapy for Common Inherited Bleeding Disorder
7. Octapharma USA Announces Availability and Distributors for wilate®, the First Replacement Therapy Developed Specifically for von Willebrand Disease
8. Octapharma Receives Orphan Drug Exclusivity Approval for wilate(R) - A Replacement Therapy Developed Specifically for von Willebrand Disease
9. Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease
10. Octapharma Group and Fresenius Kabi Enter Into an Exclusive License, Development and Supply Agreement for a HESylated Recombinant Protein
11. Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014 /PRNewswire-iReach/ -- Market ... Hydrochloride Industry, 2009-2019 is a professional and ... Oxybutynin Hydrochloride industry. The report firstly reviews ... its classification, application and manufacturing technology. The ... manufacturers of Oxybutynin Hydrochloride listing their product ...
(Date:9/19/2014)... CHICAGO, Ill. , Sept. 19, 2014  The ... ABBV ) declared a quarterly cash dividend of $0.42 ... payable Nov. 17, 2014 to stockholders of record at ... About AbbVie AbbVie is a global, research-based biopharmaceutical ... company,s mission is to use its expertise, dedicated people ...
(Date:9/19/2014)... -- Merck (NYSE: MRK ), known as MSD outside ... , is teaming with celebrity chef and cookbook author Leticia ... an educational program encouraging Hispanics with type 2 diabetes to achieve ... to help reduce the risk of serious health problems. Hispanics in ... risk for developing type 2 diabetes than non-Hispanic white adults, and ...
Breaking Medicine Technology:Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5
(Date:9/22/2014)... 2014 One key emerging trend in ... investing in R&D to develop new and advanced biomaterial ... implants. The introduction of third-generation orthopedic biomaterials such as ... will increase the growth of the market in the ... market to grow at a CAGR of 10.78 ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 AttorneyOne.com, a recognized ... latest information from the FDA on Twix . , ... Twix Unwrapped Bites 7 oz. Stand Up Pouch with specific ... for the recall is that Twix Unwrapped Bites ... contain peanuts and eggs without writing them on the ingredient ...
(Date:9/22/2014)... In CHAMPS Patient Experience's most recent blog ... Summer Meeting , Toya Gorley shares her thoughts on ... The Leader’s Board meeting this summer, which was comprised ... experience to be exhilarating! Many topics were discussed, including:, ... on the patient experience , Technology ...
(Date:9/22/2014)... September 22, 2014 Fancyflyingfox.com, the well-known wedding ... of 2014 plus size wedding dresses . In addition, ... for these fashionable plus size outfits. Each item in the ... up to 65% off. , The company has thousands ... them are now available at extremely affordable prices. Its products ...
(Date:9/21/2014)... cancer patients who smoke, those using e-cigarettes (in addition ... or less likely to have quit smoking traditional cigarettes ... a peer-reviewed journal of the American Cancer Society, the ... for helping cancer patients give up smoking. , Because ... who smoke should be advised to quit. But the ...
Breaking Medicine News(10 mins):Health News:Orthopedic Biomaterials Market to Grow at 10.78% CAGR by 2018, Forecasts a New Research Report at ReportsnReports.com 2Health News:Orthopedic Biomaterials Market to Grow at 10.78% CAGR by 2018, Forecasts a New Research Report at ReportsnReports.com 3Health News:Orthopedic Biomaterials Market to Grow at 10.78% CAGR by 2018, Forecasts a New Research Report at ReportsnReports.com 4Health News:Mars Chocolate North America Recalls Twix Bites: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:CHAMPS' Toya Gorley Discusses the Thought-Provoking Conversation at The Leader’s Board Summer Meeting 2Health News:Discounted Plus Size Wedding Dresses Available At Fancyflyingfox.com 2Health News:E-cigarettes unhelpful in smoking cessation among cancer patients 2
... a changed version of dopamine// transporter in healthy ... with substance abuse or attention deficit hyperactivity disorder ... the hypothalamus and some areas of the central ... play an important role in hormonal, cardiovascular, renal ...
... is possible to increase the heights of children who ... improved dosages of the growth hormones. ,The researchers ... that the administration of the growth hormone GH-dependent hormone ... (IGF-I) can affect the growth of children in height. ...
... have found out new information about how neuro ... be possibly slowed. ,Researchers at the Rocky ... found novel insights into how abnormal prion proteins ... mice producing prion protein without a glycophosphoinositol (GPI) ...
... be used to detect cancer, says a new study that ... and son research team had been able to bind the ... that will make the tracing of cancer cells much easier. ... factor receptor (EFGR) over their surface. This protein is not ...
... be at less risk from colorectal// cancer. And women who ... B may have even reduced chance of having colorectal cancer. ... of abnormal or malignant cells within the lining of colon ... American researchers, said that inadequate intake of dietary vitamin B ...
... problems// like cognitive impairment in children. ,Researchers across the ... of pollutants like noise from the traffic and aircrafts on ... of 2844 children in the age group of 9 to ... Netherlands, Spain, and UK. Researchers had taken the help of ...
Cached Medicine News:
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: